Primary Cutaneous Mucormycosis in an Extremely Preterm Infant Successfully Treated with Liposomal Amphotericin B

Primary Cutaneous Mucormycosis in an Extremely Preterm Infant Successfully Treated with Liposomal Amphotericin B

Cutaneous mucormycosis is a rare but often fatal invasive fungal infection that occurs most commonly in patients with diabetes, malignancy, and other immunocompromising conditions. We report an extremely preterm (

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Pediatric dermatology 2017-05, Vol.34 (3), p.e116-e119
Hauptverfasser: Lowe, Christopher D., Sainato, Rebecca J., Stagliano, David R., Morgan, Maribel M., Green, Brian P.
Format: Artikel
Sprache:eng
Schlagworte:
Amphotericin B
Amphotericin B - therapeutic use
Antifungal agents
Antifungal Agents - therapeutic use
Baby foods
Case reports
Dermatomycoses - diagnosis
Dermatomycoses - drug therapy
Dermatomycoses - microbiology
Diabetes mellitus
Follow-Up Studies
Fungal infections
Humans
Immunocompromised hosts
Infant, Extremely Premature
Infant, Newborn
Infants
Male
Malignancy
Monitoring, Physiologic
Mucormycosis
Mucormycosis - drug therapy
Mucormycosis - microbiology
Premature babies
Rhizopus - ultrastructure
Risk Assessment
Sepsis
Skin diseases
Surgery
Treatment Outcome
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Cutaneous mucormycosis is a rare but often fatal invasive fungal infection that occurs most commonly in patients with diabetes, malignancy, and other immunocompromising conditions. We report an extremely preterm (
ISSN:0736-8046
1525-1470
DOI:10.1111/pde.13124